MADELINE TERZOLA: Open Payments
NPI 1790549244 · CUYAHOGA FALLS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,681 in 100 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,069 · 2025 $1,681
Food & beverage: $1,681
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $258 |
| Novo Nordisk Inc | 14 | $227 |
| Lilly USA, LLC | 11 | $147 |
| GlaxoSmithKline, LLC. | 9 | $137 |
| Axsome Therapeutics, Inc. | 6 | $126 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $107 |
| AstraZeneca Pharmaceuticals LP | 6 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $92 |
| Exact Sciences Corporation | 5 | $91 |
| PFIZER INC. | 5 | $86 |
Products named: Ozempic, JARDIANCE, QULIPTA, XIFAXAN, Auvelity, VRAYLAR, CAPLYTA, Cologuard Collection Kit.
Industry payments across OH — which companies pay providers there.
